Updated:
Hanne Capital
Hanne Capital is a Shanghai-based private equity firm deploying across venture, growth, buyout, and PIPE transactions in Greater China.
Hanne Capital
A healthcare venture capital fund. | Founded in 2017, Hanne Capital is a healthcare venture capital fund focusing on growth opportunities in the Greater China. The Founding Partners are industry veterans with years of senior leadership experience in leading private equity fund or world-renowned multinationals in biotech, pharma and medtech; and have accomplished significant industry milestones in their previous careers. The Hanne team consists of seasoned professionals with sharp business acumen, rich experience of investment and entrepreneurial background.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Frequently asked questions
What investment strategies does Hanne Capital pursue?
Hanne Capital describes its approach as covering venture capital, growth equity, buyouts, and private investment in public equity (PIPE) transactions. This multi-stage mandate is less common among Chinese private equity firms, where managers typically specialize more narrowly. The inclusion of PIPE deals indicates Hanne Capital maintains the operational capability to invest in publicly listed companies, a skill set that requires navigating China's complex securities regulations.
Is Hanne Capital a renminbi-denominated fund, a US-dollar fund, or both?
The firm has not publicly clarified its fund currency structure. Shanghai-based managers frequently operate parallel RMB and USD vehicles to access both domestic Chinese limited partners and foreign institutional capital. Without specific disclosures from Hanne Capital, the currency composition of its funds remains unconfirmed.
Which sectors does Hanne Capital specifically target?
Hanne Capital has not published a sector-specific investment thesis. Its generalist mandate means it can evaluate opportunities across industries rather than being confined to a single vertical. In practice, many Shanghai-based generalist PE firms concentrate deal activity in areas aligned with Chinese government industrial policy priorities, including advanced manufacturing, technology, and healthcare, though Hanne Capital has not confirmed this pattern for its own portfolio.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: